Lv1
68 积分 2025-10-22 加入
Patent landscape and therapeutic evolution of Mazdutide: a dual GLP-1/Glucagon receptor agonist for obesity and type 2 diabetes
8天前
已完结
The protective effects of liraglutide in reducing lipid droplets accumulation and myocardial fibrosis in diabetic cardiomyopathy
17天前
已完结
Chlorogenic acid and ferulic acid in SMYAD alleviate diabetic cardiomyopathy by inhibiting cardiac lipotoxicity via GCGR/PPARα and GCGR/AMPK pathways
21天前
已完结
Semaglutide attenuates excessive exercise-induced myocardial injury through inhibiting oxidative stress and inflammation in rats
27天前
已完结
Protective effects and possible mechanism of 6-gingerol against arsenic trioxide-induced nephrotoxicity based on network pharmacological analysis and experimental validation
1个月前
已完结
Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control
1个月前
已完结
Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control
1个月前
已完结
Semaglutide administration protects cardiomyocytes in db/db mice via energetic improvement and mitochondrial quality control
1个月前
已完结
Artesunate improves glucose and lipid metabolism in db/db mice by regulating the metabolic profile and the MAPK/PI3K/Akt signalling pathway
2个月前
已完结
Once-Weekly Mazdutide in Chinese Adults with Obesity or Overweight
2个月前
已完结
皖公网安备34019202002308
